|
[1]NADIM MK, DURAND F, KELLUM JA, et al.Management of the critically ill patient with cirrhosis:A multidisciplinary perspective[J].J Hepatol, 2016, 64 (3) :717-735.
|
|
[2]ROSI S, PIANO S, FRIGO AC, et al.New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients:Can we use an imputed value of serum creatinine?[J].Liver Int, 2015, 35 (9) :2108-2114.
|
|
[3]ANGELI P, GINS P, WONG F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites[J].J Hepatol, 2015, 62 (4) :968-974.
|
|
[4]HUELIN P, PIANO S, SOLE, et al.Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acuteon-chronic liver failure[J].Clin Gastroenterol Hepatol, 2017, 15 (3) :438-445.e5.
|
|
[5]AMATHIEU R, AL-KHAFAJI A, SILEANU FE, et al.Significance of oliguria in critically ill patients with chronic liver disease[J].Hepatology, 2017, 66 (5) :1592-1600.
|
|
[6]de SEIGNEUX S, MARTIN PY.Preventing the progression of AKIto CKD:The role of mitochondria[J].J Am Soc Nephrol, 2017, 28 (5) :1327-1329.
|
|
[7]TANDON P, JAMES MT, ABRALDES JG, et al.Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis:A retrospective population-based cohort study[J].PLo S One, 2016, 11 (8) :e0160394.
|
|
[8]SONG TX, QI XS, GAO F, et al.Advances in diagnosis and treatment of hepatorenal syndrome type of acute kidney injury in patients with liver cirrhosis[J].J Clin Hepatol, 2017, 33 (3) :572-576. (in Chinese) 宋廷雪, 祁兴顺, 高帆, 等.肝硬化肝肾综合征型急性肾损伤的诊治进展[J].临床肝胆病杂志, 2017, 33 (3) :572-576.
|
|
[9]TREEPRASERTSUK S, WONGKARNJANA A, JARUVONGVANICHV, et al.Urine neutrophil gelatinase-associated lipocalin:A diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions[J].BMC Gastroenterol, 2015, 15:140.
|
|
[10]PUTHUMANA J, ARIZA X, BELCHER JM, et al.Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis:A systematic review and meta-analysis[J].Clin Gastroenterol Hepatol, 2017, 15 (7) :1003-1013.e3.
|
|
[11]FRANCOZ C, NADIM MK, DURAND F.Kidney biomarkers in cirrhosis[J].J Hepatol, 2016, 65 (4) :809-824.
|
|
[12]ARIZA X, SOLE, ELIA C, et al.Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis[J].PLo SOne, 2015, 10 (6) :e0128145.
|
|
[13]ARIZA X, GRAUPERA I, COLL M, et al.Neutrophil gelatinaseassociated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis[J].J Hepatol, 2016, 65 (1) :57-65.
|
|
[14]JIANG QQ, HAN MF, MA K, et al.Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis[J].World J Gastroenterol, 2018, 24 (21) :2300-2310.
|
|
[15]DONG T, ARONSOHN A, GAUTHAM REDDY K, et al.Rifaximin decreases the incidence and severity of acute kidney injury and hepatorenal syndrome in cirrhosis[J].Dig Dis Sci, 2016, 61 (12) :3621-3626.
|
|
[16]European Association for the Study of the Liver.EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J].J Hepatol, 2018, 69 (2) :406-460.
|
|
[17]DURAND F, GRAUPERA I, GINS P, et al.Pathogenesis of hepatorenal syndrome:implications for therapy[J].Am J Kidney Dis, 2016, 67 (2) :318-328.
|
|
[18]BOYER TD, SANYAL AJ, WONG F, et al.Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1[J].Gastroenterology, 2016, 150 (7) :1579-1589.e2.
|
|
[19]CAVALLIN M, KAMATH PS, MERLI M, et al.Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome:A randomized trial[J].Hepatology, 2015, 62 (2) :567-574.
|
|
[20]CAVALLIN M, PIANO S, ROMANO A, et al.Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome:A randomized controlled study[J].Hepatology, 2016, 63 (3) :983-992.
|
|
[21]FACCIORUSSO A, CHANDAR AK, MURAD MH, et al.Comparative efficacy of pharmacological strategies for management of type 1hepatorenal syndrome:A systematic review and network meta-analysis[J].Lancet Gastroenterol Hepatol, 2017, 2 (2) :94-102.
|
|
[22]GIFFORD FJ, MORLING JR, FALLOWFIELD JA.Systematic review with meta-analysis:Vasoactive drugs for the treatment of hepatorenal syndrome type 1[J].Aliment Pharmacol Ther, 2017, 45 (5) :593-603.
|
|
[23]TUJIOS SR, HYNAN LS, VAZQUEZ MA, et al.Risk factors and outcomes of acute kidney injury in patients with acute liver failure[J].Clin Gastroenterol Hepatol, 2015, 13 (2) :352-359.
|
|
[24]LI XP, WU ZP, ZHANG LL, et al.Advances in diagnosis and treatment of patients with acute-on-chronic liver failure complicated by acute kidney injury[J].J Clin Hepatol, 2016, 32 (9) :1688-1693. (in Chinese) 李小鹏, 吴振平, 张伦理, 等.慢加急性肝衰竭并发急性肾损伤的诊治进展[J].临床肝胆病杂志, 2016, 32 (9) :1688-1693.
|
|
[25]CHEN J, LIU XY, TONG JJ, et al.Clinical features of patients with acute/subacute liver failure complicated by acute kidney injury[J].J Clin Hepatol, 2018, 34 (2) :364-367. (in Chinese) 陈婧, 刘晓燕, 童晶晶, 等.急性/亚急性肝衰竭合并急性肾损伤的临床特征分析[J].临床肝胆病杂志, 2018, 34 (2) :364-367.
|
|
[26]JALAN R, SALIBA F, PAVESI M, et al.Development and validation of a prognostic score to predict mortality in patients with acuteon-chronic liver failure[J].J Hepatol, 2014, 61 (5) :1038-1047.
|
|
[27]ZANG H, LIU F, LIU H, et al.Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-onchronic liver failure (ACLF) of underlying cirrhosis[J].Hepatol Int, 2016, 10 (5) :807-818.
|
|
[28] WU ZP, ZHONG YB, LI XP, et al.The analysis of acute kidney injury in hepatitis B virus related acute-on-chronic liver failure[J].Chin J Infect Dis, 2016, 34 (12) :713-716. (in Chinese) 吴振平, 钟渊斌, 李小鹏, 等.乙型肝炎病毒相关慢加急性 (亚急性) 肝功能衰竭患者中急性肾损伤的分析[J].中华传染病杂志, 2016, 34 (12) :713-716.
|
|
[29]SHI XX, ZHANG YQ, ZHU P, et al.Prognostic risk factors in patients with acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2016, 32 (4) :700-705. (in Chinese) 石新星, 张艳琼, 朱鹏, 等.乙型肝炎相关慢加急性肝衰竭患者预后的危险因素分析[J].临床肝胆病杂志, 2016, 32 (4) :700-705.
|
|
[30]JINDAL A, BHADORIA AS, MAIWALL R, et al.Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure[J].Liver Int, 2016, 36 (1) :59-67.
|
|
[31]MAIWALL R, SARIN SK, KUMAR S, et al.Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure[J].Liver Int, 2017, 37 (10) :1497-1507.
|
|
[32]YUAN W, ZHANG YY, ZHANG ZG, et al.Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus-related acute-on-chronic liver failure[J].Am J Med Sci, 2017, 353 (5) :452-458.
|
|
[33]CHEN N, CHEN X, DING X, et al.Analysis of the high incidence of acute kidney injury associated with acute-on-chronic liver failure[J].Hepatol Int, 2018, 12 (3) :262-268.
|
DownLoad: